Experiences with Imfinzi (Durvalumab) for Bladder Cancer Survey
CSNSupportTeam
admin, CSN Member Posts: 244 Member
The Canadian government will soon be reviewing the use of Imfinzi (durvalumab) to treat muscle invasive bladder cancer. Bladder Cancer Canada will be making a submission to ensure that patient voices are represented and considered during the review process.
Does this survey apply to you?
We are looking for patients with muscle invasive bladder cancer and patients who have been treated with Imfinzi (durvalumab) to talk about their experience.
Please note that caregivers may answer questions on behalf of the patient where the patient is unable or unavailable.
YOU DO NOT NEED TO LIVE IN CANADA TOPARTICIPATE.
If you are interested in talking about your experiences, we would like to ask you to complete this survey:
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 122.3K Cancer specific
- 2.8K Anal Cancer
- 452 Bladder Cancer
- 310 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 399 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 679 Leukemia
- 799 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 240 Multiple Myeloma
- 7.2K Ovarian Cancer
- 68 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.6K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 741 Skin Cancer
- 659 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards
- 52 Research Announcements